Oxidative stress and the subcellular localization of the telomerase reverse transcriptase (TERT) in papillary thyroid cancer

Molecular and Cellular Endocrinology

Volumn 431, Issue , 2016, Pages 54-61

  Muzza, Marina ^a,b   Colombo, Carla ^a,b   Cirello, Valentina ^a,b   Perrino, Michela ^a,b   Vicentini, Leonardo ^a   Fugazzola, Laura ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

DUOX; NOX; Oxidative stress; TERT; Thyroid cancer

Indexed keywords

B RAF KINASE; CALCIUM ION; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TELOMERASE REVERSE TRANSCRIPTASE; ANTIOXIDANT; GLUTATHIONE PEROXIDASE; TELOMERASE; TERT PROTEIN, HUMAN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BRAF GENE; CANCER STAGING; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TERT GENE; THYROID PAPILLARY CARCINOMA; TISSUE DISTRIBUTION; ADOLESCENT; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; PAPILLARY CARCINOMA; PATHOLOGY; PHYSIOLOGY; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; CARCINOMA, PAPILLARY; CELL NUCLEUS; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MALE; MIDDLE AGED; MITOCHONDRIA; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; TELOMERASE; THYROID NEOPLASMS;

EID: 84966586542     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.05.005     Document Type: Article

References (47)

1. Ahmed S., Passos J.F., Birket M.J., Beckmann T., Brings S., Peters H., Birch-Machin M.A., von Zglinicki T., Saretzki G. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J. Cell Sci. 2008, 121:1046-1053. 10.1242/jcs.019372.
2. Akinci M., Kosova F., Cetin B., Sepici A., Altan N., Aslan S., Cetin A. Oxidant/antioxidant balance in patients with thyroid cancer. Acta Cir. Bras. 2008, 23:551-554. 10.1590/S0102-86502008000600013.
3. Aikawa R., Komuro I., Yamazaki T., Zou Y., Kudoh S., Tanaka M., Shiojima I., Hiroi Y., Yazaki Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Investig. 1997, 100:1813-1821. 10.1172/JCI119709.
4. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313. 10.1152/physrev.00044.2005.
5. Corti S., Donadoni C., Ronchi D., Bordoni A., Fortunato F., Santoro D., Del Bo R., Lucchini V., Crugnola V., Papadimitriou D., et al. Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction. J. Neurol. Sci. 2009, 276:170-174. 10.1016/j.jns.2008.09.030.
6. Dupuy C., Ohayon R., Valent A., Noël-Hudson M.S., Dème D., Virion A. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cdnas. J. Biol. Chem. 1999, 274:37265-37269.
7. Ekholm R., Bjorkman U. Glutathione peroxidase degrades intracellular hydrogen peroxide and thereby inhibits intracellular protein iodination in thyroid epithelium. Endocrinology 1997, 138:2871-2878.
8. Fortunato R.S., Braga W.M., Ortenzi V.H., Rodrigues D.C., Andrade B.M., Miranda-Alves L., Rondinelli E., Dupuy C., Ferreira A.C., Carvalho D.P. Sexual dimorphism of thyroid reactive oxygen species production due to higher NADPH oxidase 4 expression in female thyroid glands. Thyroid 2013, 23:111-119. 10.1089/thy.2012.0142.
9. Gérard A.C., Daumerie C., Mestdagh C., Gohy S., De Burbure C., Costagliola S., Miot F., Nollevaux M.C., Denef J.F., Rahier J., et al. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J. Clin. Endocrinol. Metab. 2003, 88:4977-4983.
10. 2-generating activities in thyroid nodular lesions. Eur. J. Endocrinol. 2008, 158:223-227. 10.1530/EJE-07-0602.
11. Grasberger H., Refetoff S. Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J. Biol. Chem. 2006, 281:18269-18272.
12. Gusdon A.M., Votyakova T.V., Reynolds I.J., Mathews C.E. Nuclear and mitochondrial interaction involving mt-Nd2 leads to increased mitochondrial reactive oxygen species production. J. Biol. Chem. 2007, 282:5171-5179.
13. Guyton K.Z., Liu Y., Gorospe M., Xu Q., Holbrook N.J. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J. Biol. Chem. 1996, 271:4138-4142. 10.1074/jbc.-271.7.3604.
14. Haendeler J., Dröse S., Büchner N., Jakob S., Altschmied J., Goy C., Spyridopoulos I., Zeiher A.M., Brandt U., Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler. Thromb. Vasc. Biol. 2009, 29:929-935. 10.1161/ATVBAHA.109.185546.
15. Haendeler J., Hoffmann J., Diehl J.F., Vasa M., Spyridopoulos I., Zeiher A.M., Dimmeler S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ. Res. 2004, 94:768-775.
16. Haendeler J., Hoffmann J., Brandes R.P., Zeiher A.M., Dimmeler S. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol. Cell. Biol. 2003, m23:4598-4610.
17. Haugen B.R., Alexander E.K., Bible K.C., Doherty G.M., Mandel S.J., Nikiforov Y.E., Pacini F., Randolph G.W., Sawka A.M., Schlumberger M., et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016, 26:1-133. 10.1089/thy.2015.0020.
18. Howie A.F., Walker S.W., Akesson B., Arthur J.R., Beckett G.J. Thyroidal extracellular glutathione peroxidase: a potential regulator of thyroid-hormone synthesis. Biochem. J. 1995, 308:713-717.
19. Ito Y., Yoshida H., Tomoda C., Uruno T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT). Anticancer Res. 2005, 1B:509-514.
20. Lacroix L., Nocera M., Mian C., Caillou B., Virion A., Dupuy C., Filetti S., Bidart J.M., Schlumberger M. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Thyroid 2001, 11:1017-1023.
21. Lassoued S., Mseddi M., Mnif F., Abid M., Guermazi F., Masmoudi H., El Feki A., Attia H.A. Comparative study of the oxidative profile in Graves' disease, Hashimoto's thyroiditis, and papillary thyroid cancer. Biol. Trace Elem. Res. 2010, 138:107-115. 10.1007/s12011-010-8625-1.
22. Li P., Tong Y., Yang H., Zhou S., Xiong F., Huo T., Mao M. Mitochondrial translocation of human telomerase reverse transcriptase in cord blood mononuclear cells of newborns with gestational diabetes mellitus mothers. Diabetes Res. Clin. Pract. 2014, 103:310-318. 10.1016/j.diabres.2013.12.024.
23. Maier J., van Steeg H., van Oostrom C., Karger S., Paschke R., Krohn K. Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 2006, 147:3391-3397. 10.1210/en.2005-1669.
24. Mano T., Shinohara R., Iwase K., Kotake M., Hamada M., Uchimuro K., Hayakawa N., Hayashi R., Nakai A., Ishizuki Y., et al. Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm. Metab. Res. 1997, 29:351-354.
25. Melo M., Rocha A.G., Vinagre J., Batista R., Peixoto J., Tavares C., Celestino R., Almeida A., Salgado C., Eloy C., et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J. Clin. Endocrinol. Metab. 2014, 99:E754-E765. 10.1210/jc.2013-3734.
26. Muzza M., Colombo C., Rossi S., Tosi D., Cirello V., Perrino M., De Leo S., Magnani E., Pignatti E., Vigo B., et al. Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization. Mol. Cell. Endocrinol. 2015, 399:288-295. 10.1016/j.mce.2014.10.019.
27. Pellegriti G., Frasca F., Regalbuto C., Squatrito S., Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J. Cancer Epidemiol. 2013, 965212. 10.1155/2013/965212.
28. Perrino M., Vannucchi G., Vicentini L., Cantoni G., Dazzi D., Colombo C., Rodari M., Chiti A., Beck-Peccoz P., Fugazzola L. Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or =2 cm. Endocr. Relat. Cancer 2009, 16:201-210. 10.1677/ERC-08-0119.
29. Piciocchi M., Cardin R., Cillo U., Vitale A., Cappon A., Mescoli C., Guido M., Rugge M., Burra P., Floreani A., et al. Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis. Transl. Res. 2015, pii: S1931-5244(15)00298-4. 10.1016/j.trsl.2015.08.012.
30. Rao G.N., Berk B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 1992, 70:593-599.
31. Sadani G.R., Nadkarni G.D. Role of tissue antioxidant defence in thyroid cancers. Cancer Lett. 1996, 109:231-235.
32. Salmeen A., Park B.O., Meyer T. The NADPH oxidases NOX4 and DUOX2 regulate cell cycle entry via a p53-dependent pathway. Oncogene 2010, 29:4473-4484. 10.1038/onc.2010.200.
33. Santos J.H., Meyer J.N., Skorvaga M., Annab L.A., Van Houten B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell. 2004, 3:399-411.
34. Saretzki G. Telomerase, mitochondria and oxidative stress. Exp. Gerontol. 2009, 44:485-492. 10.1016/j.exger.2009.05.004.
35. Senthil N., Manoharan S. Lipid peroxidation and antioxidants status in patients with papillary thyroid carcinoma in India. Asian Pac. J. Clin. Nutr. 2004, 13:391-395.
36. Shay J.W., Wright W.E. Role of telomeres and telomerase in cancer. Semin. Cancer Biol. 2011, 21:349-353.
37. Singhapol C., Pal D., Czapiewski R., Porika M., Nelson G., Saretzki G.C. Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis. PLoS One 2013, 8:e52989. 10.1371/journal.pone.0052989.
38. Stanley J.A., Neelamohan R., Suthagar E., Vengatesh G., Jayakumar J., Chandrasekaran M., Banu S.K., Aruldhas M.M. Lipid peroxidation and antioxidants status in human malignant and non-malignant thyroid tumours. Hum. Exp. Toxicol. 2015, pii: 0960327115597982.
39. Starkov A.A. Measurement of mitochondrial ROS production. Methods Mol. Biol. 2010, 648:245-255. 10.1007/978-1-60761-756-3_16.
40. Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug Discov. 2009, 8:579-591. 10.1038/nrd2803.
41. Vinagre J., Almeida A., Pópulo H., Batista R., Lyra J., Pinto V., Coelho R., Celestino R., Prazeres H., Lima L., et al. Frequency of TERT promoter mutations in human cancers. Nat. Commun. 2013, 4:2185. 10.1038/ncomms3185.
42. Wang D., Feng J., Zeng P., Yang Y., Luo J., Yang Y. Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocr. Relat. Cancer 2011, 18:773-782. 10.1530/ERC-11-0230.
43. Wang S.L., Chen W.T., Wu M.T., Chan H.M., Yang S.F., Chai C.Y. Expression of human telomerase reverse transcriptase in thyroid follicular neoplasms: an immunohistochemical study. Endocr. Pathol. 2005, 16:211-218.
44. Weyemi U., Caillou B., Talbot M., Ameziane-El-Hassani R., Lacroix L., Lagent-Chevallier O., Al Ghuzlan A., Roos D., Bidart J.M., Virion A., et al. Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues. Endocr. Relat. Cancer 2010, 17:27-37. 10.1677/ERC-09-0175.
45. Xing M., Liu R., Liu X., Murugan A.K., Zhu G., Zeiger M.A., Pai S., Bishop J. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J. Clin. Oncol. 2014, 32:2718-2726. 10.1200/JCO.2014.55.5094.
46. Yan J., Zhou Y., Chen D., Li L., Yang X., You Y., Ling X. Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells. J. Cancer 2015, 6:151-159. eCollection 2015. 10.7150/jca.10419.
47. Young O., Crotty T., O'Connell R., O'Sullivan J., Curran A.J. Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head. Neck 2010, 32:750-756. 10.1002/hed.21247.